Go Pro
LON:RIII

Rights & Issues Investment Trust Final Earnings Report

Rights & Issues Investment Trust logo
GBX 2,228.80 -31.20 (-1.38%)
As of 07/13/2026 09:56 AM Eastern

Rights & Issues Investment Trust EPS Results

Actual EPS
GBX 42.10
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Rights & Issues Investment Trust Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Rights & Issues Investment Trust Announcement Details

Quarter
Final
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Rights & Issues Investment Trust Earnings Headlines

BSEM Announces Major Corporate Milestone
BioStem Technologies (OTC: BSEM) has publicly filed a Form 10 registration statement with the SEC, advancing its progress toward a planned Nasdaq uplisting. CEO Jason Matuszewski says the filing is expected to enhance credibility, expand capital access, and improve market visibility. BioStem is a regenerative medicine company commercializing perinatal tissue allograft products via its proprietary BioRetain, CryoTek, and SteriTek processing technologies.tc pixel
See More Rights & Issues Investment Trust Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Rights & Issues Investment Trust? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rights & Issues Investment Trust and other key companies, straight to your email.

About Rights & Issues Investment Trust

Rights and Issues Investment Trust Public Limited Company is a self-managed investment trust. The firm invests in public equity markets of the United Kingdom. It invests in stocks of small-cap companies. The firm benchmarks the performance of its portfolio against the FTSE All share index. Rights and Issues Investment Trust Public Limited Company was founded in 1963 and is based in London, United Kingdom.

View Rights & Issues Investment Trust Profile